Literature DB >> 31655432

Recent developments on (-)-colchicine derivatives: Synthesis and structure-activity relationship.

Abdullah A Ghawanmeh1, Hussein M Al-Bajalan2, Mukram Mohamed Mackeen3, Feras Q Alali4, Kwok Feng Chong5.   

Abstract

(-)-Colchicine, an anti-microtubulin polymerization agent, is a valuable medication and the drug of choice for gout, Behçet's disease and familial Mediterranean fever. It has a narrow therapeutic index due to its high toxicity towards normal cells. Nonetheless, numerous (-)-colchicine derivatives have been synthesized and studied for their structure-activity relationship and preferential toxicity. Different functional groups such as amides, thioamides, N-arylurea and 8,12-diene cyclic have been incorporated into (-)-colchicine, resulting in derivatives (with moieties) that include electron-withdrawing and electron-donating groups. This review article focuses on recent developments in the chemical synthesis of (-)-colchicine derivatives, the substituents used, the functional groups linked to the substituents, the moieties and biological studies. Moreover, the current classification of derivatives based on the (-)-colchicine rings, namely ring A, B, and C (-)-colchicine derivatives, is discussed. This work demonstrates and summarizes the significance of (-)-colchicine derivatives in the biological field, and discusses their promising therapeutics for the future.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  (−)-Colchicine; (−)-Colchicine derivatives; Structure-activity relationship

Mesh:

Substances:

Year:  2019        PMID: 31655432     DOI: 10.1016/j.ejmech.2019.111788

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Tubulin Inhibitors: A Chemoinformatic Analysis Using Cell-Based Data.

Authors:  Edgar López-López; Carlos M Cerda-García-Rojas; José L Medina-Franco
Journal:  Molecules       Date:  2021-04-24       Impact factor: 4.411

2.  Antiproliferative Potential of Gloriosine: A Lead for Anticancer Drug Development.

Authors:  Bharat Goel; Biswajit Dey; Essha Chatterjee; Nancy Tripathi; Nivedita Bhardwaj; Sanjay Kumar; Santosh Kumar Guru; Shreyans K Jain
Journal:  ACS Omega       Date:  2022-08-12

3.  Regioselective approach to colchiceine tropolone ring functionalization at C(9) and C(10) yielding new anticancer hybrid derivatives containing heterocyclic structural motifs.

Authors:  Krystian Pyta; Natalia Skrzypczak; Piotr Ruszkowski; Franz Bartl; Piotr Przybylski
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.